First Trust NYSE Arca Biotechnology Index Fund
129 hedge funds and large institutions have $2.46B invested in First Trust NYSE Arca Biotechnology Index Fund in 2015 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 48 increasing their positions, 39 reducing their positions, and 22 closing their positions.
413% more call options, than puts
Call options by funds: $6.59M | Put options by funds: $1.28M
25% more funds holding in top 10
Funds holding in top 10: 8 → 10 (+2)
23% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 39
21% more capital invested
Capital invested by funds: $2.04B → $2.46B (+$422M)
18% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 22
5.14% more ownership
Funds ownership: 66.54% → 71.68% (+5.1%)
2% more funds holding
Funds holding: 127 → 129 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$110M |
| 2 |
LPL Financial
San Diego,
California
|
+$30.3M |
| 3 |
Morgan Stanley
New York
|
+$23M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$10.1M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$5.01M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$9.4M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$8.58M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$5.86M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$4.09M |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$4M |
FBT Hedge Fund Activity: Q4 2015 in Review
129 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q4 2015, worth a combined $2.46B — up 21% from $2.04B a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new FBT positions and 22 closed out — a net gain of 4 holders — while 48 added to existing stakes and 39 trimmed.
The largest buyer was First Trust Advisors, adding an estimated $110M. The largest seller was Citadel Advisors, exiting entirely with an estimated $9.4M sold.
- 129 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q4 2015, up from 127 in Q3 2015.
- Funds reported $2.46B of First Trust NYSE Arca Biotechnology Index Fund stock for Q4 2015, up 21% quarter-over-quarter.
- 26 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q4 2015 and 22 closed out, a net change of +4 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q4 2015 was First Trust Advisors, an estimated $110M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q4 2015 was Citadel Advisors, an estimated $9.4M sold.
Based on aggregated 13F filings for Q4 2015.